Global Drugs of Abuse Testing Market Overview And Scope:
Global Drugs of Abuse Testing Market Size was estimated at USD 3011.25 million in 2022 and is projected to reach USD 3954.42 million by 2028, exhibiting a CAGR of 4.65% during the forecast period.
The Global Drugs of Abuse Testing Market Report 2023 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Drugs of Abuse Testing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Quest Diagnostics, F. Hoffmann La-Roche, Siemens, Thermo Fisher Scientific, Abbott, Shimadzu, Laboratory Corporation of America
Global Drugs of Abuse Testing Market Segmentation
By Type, Drugs of Abuse Testing market has been segmented into:Psychostimulants
Narcotic
Hallucinogens
Sedatives
Others
By Application, Drugs of Abuse Testing market has been segmented into:
Hospitals
Diagnostics Laboratories
Forensic Laboratories
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Drugs of Abuse Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Drugs of Abuse Testing market.
Top Key Players Covered in Drugs of Abuse Testing market are:
Quest Diagnostics
F. Hoffmann La-Roche
Siemens
Thermo Fisher Scientific
Abbott
Shimadzu
Laboratory Corporation of America
Objective to buy this Report:
1. Drugs of Abuse Testing analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Drugs of Abuse Testing market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Drugs of Abuse Testing Market by Type
5.1 Drugs of Abuse Testing Market Overview Snapshot and Growth Engine
5.2 Drugs of Abuse Testing Market Overview
5.3 Psychostimulants
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Psychostimulants: Geographic Segmentation
5.4 Narcotic
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Narcotic: Geographic Segmentation
5.5 Hallucinogens
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2030F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Hallucinogens: Geographic Segmentation
5.6 Sedatives
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2030F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Sedatives: Geographic Segmentation
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2016-2030F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation
Chapter 6: Drugs of Abuse Testing Market by Application
6.1 Drugs of Abuse Testing Market Overview Snapshot and Growth Engine
6.2 Drugs of Abuse Testing Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Diagnostics Laboratories
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Diagnostics Laboratories: Geographic Segmentation
6.5 Forensic Laboratories
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2030F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Forensic Laboratories: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2030F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Drugs of Abuse Testing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Drugs of Abuse Testing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Drugs of Abuse Testing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 QUEST DIAGNOSTICS
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 F. HOFFMANN LA-ROCHE
7.4 SIEMENS
7.5 THERMO FISHER SCIENTIFIC
7.6 ABBOTT
7.7 SHIMADZU
7.8 LABORATORY CORPORATION OF AMERICA
Chapter 8: Global Drugs of Abuse Testing Market Analysis, Insights and Forecast, 2016-2030
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Psychostimulants
8.2.2 Narcotic
8.2.3 Hallucinogens
8.2.4 Sedatives
8.2.5 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Diagnostics Laboratories
8.3.3 Forensic Laboratories
8.3.4 Others
Chapter 9: North America Drugs of Abuse Testing Market Analysis, Insights and Forecast, 2016-2030
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Psychostimulants
9.4.2 Narcotic
9.4.3 Hallucinogens
9.4.4 Sedatives
9.4.5 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Diagnostics Laboratories
9.5.3 Forensic Laboratories
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Drugs of Abuse Testing Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Psychostimulants
10.4.2 Narcotic
10.4.3 Hallucinogens
10.4.4 Sedatives
10.4.5 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Diagnostics Laboratories
10.5.3 Forensic Laboratories
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Drugs of Abuse Testing Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Psychostimulants
11.4.2 Narcotic
11.4.3 Hallucinogens
11.4.4 Sedatives
11.4.5 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Diagnostics Laboratories
11.5.3 Forensic Laboratories
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Drugs of Abuse Testing Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Psychostimulants
12.4.2 Narcotic
12.4.3 Hallucinogens
12.4.4 Sedatives
12.4.5 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Diagnostics Laboratories
12.5.3 Forensic Laboratories
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Drugs of Abuse Testing Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Psychostimulants
13.4.2 Narcotic
13.4.3 Hallucinogens
13.4.4 Sedatives
13.4.5 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Diagnostics Laboratories
13.5.3 Forensic Laboratories
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Drugs of Abuse Testing Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Psychostimulants
14.4.2 Narcotic
14.4.3 Hallucinogens
14.4.4 Sedatives
14.4.5 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospitals
14.5.2 Diagnostics Laboratories
14.5.3 Forensic Laboratories
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Drugs of Abuse Testing Scope:
Report Data
|
Drugs of Abuse Testing Market
|
Drugs of Abuse Testing Market Size in 2022
|
USD 3011.25 million
|
Drugs of Abuse Testing CAGR 2023 - 2030
|
4.65%
|
Drugs of Abuse Testing Base Year
|
2022
|
Drugs of Abuse Testing Forecast Data
|
2023 - 2030
|
Segments Covered
|
By Type, By Application, And by Regions
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
Key Companies Profiled
|
Quest Diagnostics, F. Hoffmann La-Roche, Siemens, Thermo Fisher Scientific, Abbott, Shimadzu, Laboratory Corporation of America.
|
Key Segments
|
By Type
Psychostimulants Narcotic Hallucinogens Sedatives Others
By Applications
Hospitals Diagnostics Laboratories Forensic Laboratories Others
|
Research Methodology